Dr. Alka Singal

MD | Psychiatry | Addiction Medicine


  2900 W Prospect Rd, Fort Lauderdale
     Florida, 33309-2519
  954-731-1000    954-497-3857 Maps & Directions
Dr. Alka Singal is a Fort Lauderdale, Florida based psychiatrist who is specialized in Addiction Medicine. Her current practice location is 2900 W Prospect Rd, Fort Lauderdale. Patients can reach her at 954-731-1000 or can fax her at 954-497-3857. Dr. Alka Singal is MD in Addiction Medicine and her NPI number (Unique professional ID assigned by NPPES) is 1053428607.
Dr. Alka Singal focuses on the evaluation, diagnosis, and treatment of people who have one or more disorders related to addictions like illegal drugs, alcohol, and prescription medication and other substances.
Complete Profile:
Dr. Alka Singal speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Alka Singal
Specialization: Addiction Medicine
Gender:Female
Credentials: MD
Practice Address:2900 W Prospect Rd, Fort Lauderdale,
Florida, 33309-2519
Phone:954-731-1000
Fax:954-497-3857
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1053428607
NPI Enumeration Date: 23 Aug, 2006
NPI Last Update On: 30 Nov, 2017

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Alka Singal
1135 Nw 139th Ave,
Pembroke Pines, Florida
Zip: 33028-2339
Phone Number: 954-449-1746
Fax Number: 954-449-1736
Patients can reach Dr. Alka Singal at 2900 W Prospect Rd, Fort Lauderdale, Florida or can call to book an appointment on 954-731-1000.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.